StockData
HeartBeam, Inc. logo

HeartBeam, Inc. (BEAT) stock

BEATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BEATW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.34+0.01 (+1.98%)

Close on Nov 18, 2026Market cap $19.18MP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026

Valuation

Market cap
$19.18M
P/E ratio
–
Price to sales
–
Price to book
2.35
Dividend yield
–
Free cash flow yield
-73.05%

Fundamentals

Net income
-$20.30M
EPS, diluted
-$0.52
Free cash flow
-$14.01M
Book value per share
$0.15
Diluted shares
53M

Trading

Previous close
$0.33
Open
$0.34
Day's range
$0.33 – $0.35
Volume
622,726
Average volume (20 days)
1,285,554
52-week range
$0.32 – $4.00
RSI (14 days)
37.8
Volatility (1 year)
163.8%
Relative volume
0.11×

Market cap history

Month-end market cap since 2021, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 18, 2026. The S&P 500 is measured by the SPY fund.

PeriodBEATS&P 500DifferenceBEAT per yearS&P 500 per year
1 month-21.9%-4.3%−17.6 pts
3 months-29.1%-4.6%−24.5 pts
Year to date-85.8%+7.9%−93.7 pts
1 year-80.0%+11.8%−91.8 pts
3 years-73.8%+68.0%−141.8 pts-36.0%+18.9%
5 years-91.9%+66.2%−158.1 pts-39.4%+10.7%

Seven years at a glance

Fiscal years 2019 to 2025 and trailing twelve months, USD

Operating income

-$20.41M

Net income

-$20.30M

EPS, diluted

-$0.52

Free cash flow

-$14.01M
Reported periodTrailing twelve months

Press releases

Releases HeartBeam filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About HeartBeam

Surgical & Medical Instruments & Apparatus

HeartBeam is a medical technology company that develops ambulatory cardiac monitoring solutions designed for use outside clinical environments. The company's primary offering is the HeartBeam System, a cable-free cardiac monitoring platform comprising a credit-card-sized three-dimensional electrocardiogram (ECG) recording device, a patient mobile application, cloud-based algorithms, and a web-based physician portal. The system records electrical signals from the heart across three dimensions to synthesize twelve-lead ECG readings for remote arrhythmia assessment, supported by continuous access to on-demand cardiologists. Target customers include concierge physicians, preventive cardiology practices, and hospital cardiology departments.

Company profile, executives and history

HeartBeam stock: common questions

What is HeartBeam's stock price?

BEAT closed at $0.34 on Nov 18, 2026, up 1.98% on the day. Over the past 52 weeks it traded between $0.32 and $4.00.

What is HeartBeam's market cap?

HeartBeam was worth $19.18M at the close on Nov 18, 2026: the share price times the diluted shares outstanding.

What is BEAT's P/E ratio?

HeartBeam lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.52), so it has no meaningful P/E ratio.

Does HeartBeam pay a dividend?

No. HeartBeam has not paid a cash dividend over the last twelve months.

How has BEAT stock performed over the past year?

Including dividends, BEAT returned -80.0% over the past year, against +11.8% for the S&P 500.

Who are HeartBeam's competitors?

Companies most similar to HeartBeam by business, industry and size include BTCY, IRTC, EBRCZ, CVRX, KMTS.

See a number that looks wrong?